The $9.95 Million Question: Is ESR Worth Keeping? A new ALCOR Scientific sponsored peer-reviewed study published in ClinicoEconomics and Outcomes Research makes a powerful economic case for retaining ...
ESR Labs will bring additional scale to Accenture’s focus on smart connected solutions and mobility services Accenture has agreed to acquire ESR Labs, a German embedded software company that works for ...
Efforts to reduce unnecessary medical testing have led some hospitals to scale back the use of a decades-old inflammation test known as the erythrocyte sedimentation rate, or ESR. But new research ...
Accenture plc ACN yesterday announced that it has inked a deal to acquire ESR Labs — a Munich-based company that develops embedded software for leading German car brands and suppliers — for an ...
Accenture (NYSE: ACN) recently announced the acquisition of ESR Labs, a Munich-based company that develops embedded software for German car brands and suppliers. This news comes just days after ...
The erythrocyte sedimentation rate (ESR) remains one of the most enduring laboratory tests for assessing systemic inflammation and monitoring disease activity. Grounded in the principle that red blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results